Registered entities
4d Molecular Therapeutics, Inc.
Reg. No. 47-3506994United States
4D MOLECULAR THERAPEUTICS, INC.
Reg. No. 1650648United States
Innovation
21 patent families (9 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 2,237 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 6 |
| 2022 | 8 |
| 2023 | 9 |
| 2024 | 13 |
| 2025 | 14 |
| 2026 | 10 |
Social engagement
Social engagement: 22.3K social following, 1 post in the last 12 months — below the industry typical range.
Investor mix
20 investors on record; lead investors include Viking Global Investors; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 55% |
| Private equity | 3 | 15% |
| Bank & private debt | 1 | 5% |
| Other / undisclosed | 5 | 25% |
Hiring activity
Hires periodically
12 roles tracked across 3 of the last 12 months
4 Mar 2026 · Vice President, Supply Chain · Emeryville
2 Mar 2026 · Clinical Technology Manager, IT · Emeryville
2 Mar 2026 · Administrative Assistant (Contractor) · Emeryville
24 Feb 2026 · Senior Director, Biostatistics · Emeryville
24 Feb 2026 · Associate Director, Biostatistics · Emeryville
Based on job postings tracked across public sources.
Recent activity
1 Jul 2026
Event
APRIS 2026 Annual Meeting